3billion Goes Public on KOSDAQ, South Korea’s Stock Exchange for Growing Companies!
- News | 24. 11. 15
We’re thrilled to announce that 3billion, founded in 2016 as an AI-driven rare disease diagnostic company, is now officially listed on KOSDAQ, South Korea’s stock exchange for innovative and growing companies. This achievement marks an important milestone in strengthening our global presence and advancing our commitment to innovation in rare disease diagnostics.
Moving forward, 3billion will continue to empower healthcare professionals worldwide with our proprietary AI technology to deliver fast, accurate diagnoses to patients. We are ready to embark on this exciting journey of growth and global impact!
Join us as we take the next big leap in rare disease diagnostics.
Do you find this post helpful?
Click the button below to copy and share the link.
3billion Inc.
3billion is dedicated to creating a world where patients with rare diseases are not neglected in diagnosis and treatment.
